According to a letter (PDF) signed by US Senators Elizabeth Warren (D-Mass), Angela Alsobrooks (D-Md), Richard Blumenthal ...

Cytokinetics is one of the first drugmakers to benefit from the UK's dual regulatory and reimbursement appraisals, getting a ...

FDA advisors have voted that Capricor Therapeutics has not provided strong evidence of efficacy for its cell therapy for ...

For most of biopharma's history, organisations treated this kind of reasoning as something that would transfer on its own ...

As a result, professionals responsible for lab operations, facilities, engineering, and asset management are taking on a more strategic role in supporting scientific excellence while driving ...

Moreover, there are blood tests based on biomarkers that measure the body's immune response to infection, such as the Qiagen ...

A US judge has ordered that Novo Nordisk must face some allegations in court that it defrauded investors by making misleading ...

AbbVie's fast-growing JAK inhibitor Rinvoq has been cleared for alopecia areata in the EU, the first market for the hair loss ...

The European Commission has approved Otsuka's Dawnzera for the prevention of recurrent attacks in rare disease hereditary angioedema (HAE), a drug that can be self-administered by patients with weeks ...

The latter approval is seen as the lever that will finally push annual sales of the drug above the $1 billion threshold, ...

A dual GLP-1 and glucagon agonist developed by Altimmune has been shown to reduce drinking in people with alcohol use ...

Generic and biosimilar drug producer Sandoz has agreed a $265 million settlement that aims to put allegations of price-fixing brought in a Pennsylvania lawsuit behind it. The agreement – which still ...